» Articles » PMID: 29900420

Cell-free Synthetic Biology for Biosynthesis of Pharmaceutical Natural Products

Overview
Specialty Biotechnology
Date 2018 Jun 15
PMID 29900420
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Natural products with significant biological activities continuously act as rich sources for drug discovery and development. To harness the potential of these valuable compounds, robust methods need to be developed for their rapid and sustainable production. Cell-free biosynthesis of pharmaceutical natural products by reconstruction of the entire biosynthetic pathways represents one such solution. In this review, we focus on biosynthesis of two important classes of natural products, polyketides (PKs) and nonribosomal peptides (NRPs). First, we summarize purified enzyme-based systems for the biosynthesis of PKs, NRPs, and PK/NRP hybrids. Then, we introduce the cell-free protein synthesis (CFPS)-based technology for natural product production. With that, we discuss challenges and opportunities of cell-free synthetic biology for biosynthesis of natural products.

Citing Articles

Advanced Technologies for Large Scale Supply of Marine Drugs.

Martinez H, Santos M, Pedraza L, Testera A Mar Drugs. 2025; 23(2).

PMID: 39997193 PMC: 11857447. DOI: 10.3390/md23020069.


Cell-Free Systems: Ideal Platforms for Accelerating the Discovery and Production of Peptide-Based Antibiotics.

Park H, Jin H, Kim D, Lee J Int J Mol Sci. 2024; 25(16).

PMID: 39201795 PMC: 11354240. DOI: 10.3390/ijms25169109.


Hydrogel-Based Multi-enzymatic System for Biosynthesis.

Wu H, Zheng B Adv Biochem Eng Biotechnol. 2023; 186:51-76.

PMID: 37306702 DOI: 10.1007/10_2023_220.


Advancing synthetic biology through cell-free protein synthesis.

Yue K, Chen J, Li Y, Kai L Comput Struct Biotechnol J. 2023; 21:2899-2908.

PMID: 37216017 PMC: 10196276. DOI: 10.1016/j.csbj.2023.05.003.


Cell-Free Expression of a Therapeutic Protein Serratiopeptidase.

Meng Y, Yang M, Liu W, Li J Molecules. 2023; 28(7).

PMID: 37049893 PMC: 10095615. DOI: 10.3390/molecules28073132.


References
1.
Zemella A, Thoring L, Hoffmeister C, Kubick S . Cell-Free Protein Synthesis: Pros and Cons of Prokaryotic and Eukaryotic Systems. Chembiochem. 2015; 16(17):2420-31. PMC: 4676933. DOI: 10.1002/cbic.201500340. View

2.
Sattely E, Fischbach M, Walsh C . Total biosynthesis: in vitro reconstitution of polyketide and nonribosomal peptide pathways. Nat Prod Rep. 2008; 25(4):757-93. DOI: 10.1039/b801747f. View

3.
Zhang W, Ostash B, Walsh C . Identification of the biosynthetic gene cluster for the pacidamycin group of peptidyl nucleoside antibiotics. Proc Natl Acad Sci U S A. 2010; 107(39):16828-33. PMC: 2947877. DOI: 10.1073/pnas.1011557107. View

4.
Izumikawa M, Cheng Q, Moore B . Priming type II polyketide synthases via a type II nonribosomal peptide synthetase mechanism. J Am Chem Soc. 2006; 128(5):1428-9. PMC: 2531066. DOI: 10.1021/ja0559707. View

5.
Walsh C . Polyketide and nonribosomal peptide antibiotics: modularity and versatility. Science. 2004; 303(5665):1805-10. DOI: 10.1126/science.1094318. View